Keywords: update, blow, orion, deramciclane, fails, pharma, finland

Update: Blow to Orion as deramciclane fails

Article | 24 February 2003

Orion Pharma of Finland and partner Pharmacia have decided todiscontinue the development of deramciclane for generalized anxiety disorder, owing to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in